Valentyn Shapovalov

English · Українська · Español · Français · Deutsch · Português

Valentyn Shapovalov is a contributor to the publications documented in this wiki. Also appears as Valentin Shapovalov; Ukrainian name (original script): Шаповалов Валентин Валерійович. He is distinct from Valerii Shapovalov.

Identity and public profiles

• ORCID 0000-0002-9329-0195.
• ResearchGate profile.

• Google Scholar profile.

Dated institutional context

The SRUMPL management page, dated 16 May 2026, identifies him as president. This is a dated institutional record, not a role inferred from publication initials.

SRUMPL management record and the specific publications below provide the source context.

Selected publication connections

• With Andriy Gudzenko, Valeriy Shapovalov and Viktoriya Shapovalova: the 2021 forensic-pharmacy study of complaints about medicine provision for privileged patient categories, DOI 10.31435/rsglobal_sr/30042021/7517.
• With Oleksandr Veits, Valerii Shapovalov and Andrii Diachenko: US drug-trafficking policy and its possible relevance for Ukraine (23 September 2025), publisher record.
• With Andrii Diachenko and Anatolii Derkach: healthcare reform and legal relationships in the United States and Ukraine, publisher record. The landing page gives 13 February 2026; an inconsistent received date in the PDF should not be substituted.

Shared conceptual publications

The publisher records list this author among the six coauthors of The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration (12 December 2025) and Vision 2035 – Medico-Pharmaceutical Law for Human Security (6 March 2026). These bylines apply to those editions, not automatically to every later revision or conceptual article.

• 2025 monograph, DOI 10.53933/3qgntf55.
• 2026 book, DOI 10.53933/b91avw28.

Reading the record

Publication coauthorship, institutional office and contribution to an individual concept are different relationships. See Research network for dated, work-specific connections and People and attribution for editorial principles. Profile databases can contain duplicate records or name variants; the ORCID identifier is an identity key, not proof that every listed claim has been independently audited.

Further documented collaboration

With Yurii Titarenko: the 2024 paper on proposed technologies and falsified-medicine risks, primary record, DOI 10.53933/sspmlp.v4i2.149. Additional formulation and antituberculosis-medicine collaborations are documented on Iurii Titarenko and Research network. These are work-specific connections, not claims of demonstrated clinical effectiveness.

Public research records before 2021

The selected public records include pharmacy compounding (2017), HIV/AIDS and cancer medicine access (2018), palliative-care medicine controls (2019) and pandemic-era public health (2020). See ORCID bibliography before 2021 for the individual public work links and Research before 2021 for publisher-grounded descriptions. These are bibliographic topic descriptions, not a claim of sole authorship or full-text review of every work.

Source: public ORCID profile and the exact work records linked in the guide.